- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05571449
Effektiviteten av bruken av 3D-utskriftsmodeller ved behandling av tibialplatåfrakturer: en randomisert klinisk studie
Effektiviteten av bruken av 3D-utskriftsmodeller ved behandling av tibialplatåfrakturer: en prospektiv randomisert klinisk studie
TIBIA3D is a randomized, open and prospective clinical trail that evaluates the use of preoperative 3D printing in the surgical treatment of patients with tibial plateau fractures
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Randomized, open and prospective study.
Once the surgical indication for osteosynthesis has been established after having suffered a tibial plateau fracture, the patients will be randomized in a 1:1 ratio to one of the tfollowing treatment groups:
Control group: images obtained by plain radiography and computed tomography are used in the planning of osteosynthesis of the tibial plateau fracture.
Experimental group: in the planning of tibial plateau fracture osteosynthesis, in addition to images obtained by plain radiography and computed tomography, a three-dimensional plastic model printed by processing the tomography images is used.
Patients (or their legal representatives) must sign the consent before randomization.
After surgery, a follow-up will be carried out at 3, 6 and 12 months, visits in which data will be collected regarding the physical examination, radiological examination, pain and questionnaires will be filled out regarding the functionality of the knee and perception of health status.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Madrid
-
Majadahonda, Madrid, Spania, 28222
- Hospital Universitario Puerta de Hierro Majadahonda
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients with tibial plateau fracture requiring surgical treatment.
- Age equal to or greater than 18 years.
- Signature of informed consent in writing according to current legislation before collecting any information.
Exclusion Criteria:
- Pregnancy in progress.
- Presence of serious systemic pathology or another situation that contraindicates treatment
- Presence of other fractures in the ipsilateral femur or tibia that condition the surgical treatment of the tibial plateau fracture.
- Findings in the physical examination, in the results of the tests or other medical, social or psychopathological factors that, in the opinion of the investigators, could negatively influence the study.
- Inability to grant informed consent in the absence of a legal representative.
- Inability to follow instructions or collaborate during the development of the study.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Experimental group
Planning of tibial plateau fracture osteosynthesis by using a three-dimensional model of the fracture. |
Internal fixation of the fracture Plain radiograph and CT images are used A 3D plastic model made from CT images is used |
|
Annen: Control group
Standard planning of tibial plateau fracture osteosynthesis (by plain radiography and computed tomography imaging). |
Internal fixation of the fracture Plain radiograph and CT images are used |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Surgical time
Tidsramme: Week 1
|
Surgical time will include the time from skin incision to wound closure |
Week 1
|
|
Fluoroscopy time.
Tidsramme: Week 1
|
Intraoperative fluoroscopy time will be counted after incision and before wound closure. |
Week 1
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Ease of surgical planning with 3d printing
Tidsramme: Week 1
|
Form filled out by the surgeon before the intervention to find out if the three-dimensional impression of the fracture has changed from the original preoperative planning that it had previously |
Week 1
|
|
Complications
Tidsramme: Week 1 - 12 months
|
The incidence of complications, such as superficial wound infection, deep wound infection, iatrogenic neurological symptoms, reduction loss and fixation failure, will be recorded in both groups. |
Week 1 - 12 months
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Visual Analogis Scale for Pain
Tidsramme: 6 weeks - 12 months
|
VAS measure the intensity of the pain that the patient describes. It consists of a horizontal line of 10 centimeters, with 0cm being "no pain" and 10cm being "extreme pain". |
6 weeks - 12 months
|
|
KOOS Questionarie
Tidsramme: 6 weeks - 12 months
|
The Knee injury and Osteoarthritis Outcome Score (KOOS) has been developed as an instrument to assess the patient's opinion about their knee and associated problems It has to separate sections ("Knee Score" and "Functional Score") that are scored from 0 to 100 with lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions. |
6 weeks - 12 months
|
|
EuroQol-5D Questionarie
Tidsramme: 6 weeks - 12 months
|
Generic instrument for measuring health-related quality of life, in which the individual himself assesses his health status (0-100 score) |
6 weeks - 12 months
|
|
WOMAC Questionarie
Tidsramme: 6 weeks - 12 months
|
It is the most widely used questionnaire to assess the results after knee and hip arthroplasty in patients with osteoarthritis in the lower extremity (0-68 score) |
6 weeks - 12 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Pedro J Torrijos Garrido, MD, PhD, Hospital Universitario Puerta de Hierro
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- TIBIA3D
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .